Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%.
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine